|
- 2015
Abnormal Excitability and Episodic Low-Frequency Oscillations in the Cerebral Cortex of the tottering MouseDOI: 10.1523/JNEUROSCI.3107-14.2015 Abstract: The Ca2+ channelopathies caused by mutations of the CACNA1A gene that encodes the pore-forming subunit of the human Cav2.1 (P/Q-type) voltage-gated Ca2+ channel include episodic ataxia type 2 (EA2). Although, in EA2 the emphasis has been on cerebellar dysfunction, patients also exhibit episodic, nonmotoric abnormalities involving the cerebral cortex. This study demonstrates episodic, low-frequency oscillations (LFOs) throughout the cerebral cortex of tottering ( tg / tg ) mice, a widely used model of EA2. Ranging between 0.035 and 0.11 Hz, the LFOs in tg / tg mice can spontaneously develop very high power, referred to as a high-power state. The LFOs in tg / tg mice are mediated in part by neuronal activity as tetrodotoxin decreases the oscillations and cortical neuron discharge contain the same low frequencies. The high-power state involves compensatory mechanisms because acutely decreasing P/Q-type Ca2+ channel function in either wild-type (WT) or tg / tg mice does not induce the high-power state. In contrast, blocking l-type Ca2+ channels, known to be upregulated in tg / tg mice, reduces the high-power state. Intriguingly, basal excitatory glutamatergic neurotransmission constrains the high-power state because blocking ionotropic or metabotropic glutamate receptors results in high-power LFOs in tg / tg but not WT mice. The high-power LFOs are decreased markedly by acetazolamide and 4-aminopyridine, the primary treatments for EA2, suggesting disease relevance. Together, these results demonstrate that the high-power LFOs in the tg / tg cerebral cortex represent a highly abnormal excitability state that may underlie noncerebellar symptoms that characterize CACNA1A mutations
|